One-Year Disease Outcomes in Stage III Non-Small Cell Lung Cancers Treated with Trimodality Therapy vs Concurrent Chemoradiation and Durvalumab

Authors :: Abraham J. Wu
Charles B. Simone
Daphna Y. Gelblum
David R. Jones
Andreas Rimner
Annemarie F. Shepherd
Zhigang Zhang
Stephanie Lobaugh
Daniel R. Gomez
Charles M. Rudin
Michael Offin
James M. Isbell
Narek Shaverdian
Mark G. Kris
Jamie E. Chaft
Matthew D. Hellmann
Source :: International Journal of Radiation Oncology*Biology*Physics. 108:e113
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
Durvalumab
Lung
business.industry
Disease outcome
Concurrent chemoradiation
medicine.anatomical_structure
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
Non small cell
Stage (cooking)
business

Tools